Birds's Eye
Technicals
MovingAverage
Candlestick
PivotPoint
Fin Statements
Beta&Vols
Tech ChartsFundamental Analysis of Anuh Pharma Limited - Growth / Value Index
ANUHPHR - Valuation Highlights
Valuation Analysis
Undervalued - Price to Intrinsic Value of 0.949
Tremendous increasing in Book Value last 3 year
Valuation Key Ratios
| Ratio | TTM | Latest FY | Yoy Change | MRQ | Screener/ About |
|---|---|---|---|---|---|
| Price to Earning | 20.52 | 15.79 | 0 % | ||
| Price to Book | 3.10 | 2.29 | 0 % | 2.43 | |
| Price to Sales | 1.09 | 1.13 | 0 % | ||
| Enterprise Value to EBITDA Multiple | 10.50 | 0 % |
ANUHPHR - Profitability Highlights
Profitability Analysis
Piotroski F Score - Stable Value of 4.0
Good Return On Capital Employed of 14.07
Good Return on Equity of 15.10% is achieved by the company
Tsr Profitability Index - Poor Score of 20.62
Very Low Dividend Yield of 0 %
Low Earning Yield of 4.87 %
EPS decline for last four quarters
Profitability Key Ratios
| Ratio | TTM | Latest FY | Yoy Change | MRQ | Screener/ About |
|---|---|---|---|---|---|
| Return On Equity | 15.10 | 14.52 | -29.58 % | 2.33 | |
| Return On Asset | 9.89 | 9.35 | -30.65 % | 1.50 | |
| Net Profit Margin | 5.30 | 7.16 | -22.89 % | 4.09 | |
| Operating Profit Margin | 6.93 | 7.79 | -23.85 % | 4.85 | |
| EBITDA Margin | 8.54 | 10.64 | -21.11 % | 6.92 |
Highlights
| Market Cap | 7947.78 M |
| Enterprise Value | 7860.49 M |
| Price/Book TTM | 3.10 |
| Outstanding Share | 100211 K |
| Float/ Outstanding Share | 0% |
| Dividend Yield | 0 % |
Share Holding
Guru Numbers
| Price/Graham No | 1.49 |
| Peter Lynch Ratio | -1.03 |
| Piotroski F Score | 4.00 |
| Altman Z Score | 5.33 |
| Sloan Ratio | 0.059 |
| Peter Lynch Fair Value | 81.70 |
ANUHPHR - Growth Highlights
Growth Analysis
Annual sales of the company is increased for three years in a row
Steady increase in Total Assets for last 3 Years
Growth Key Fields
| Field | TTM | YoY Growth | QoQ Growth |
|---|---|---|---|
| Revenue | 730.01 (Cr) | 2.24 % | 0.322 % |
| Gross Profit | 163.92 (Cr) | 1.12 % | 22.13 % |
| EBITDA | 62.33 (Cr) | 19.34 % | 5.99 % |
| Net Profit | 38.71 (Cr) | 21.16 % | 8.31 % |
| EPS | 3.87 | 21.12 % | NA |
ANUHPHR - Stability Highlights
Stability Analysis
Tsr Stability Index - Excellent Score of 87.50
Altman Z Score of 5.33 suggests good Stability
Stability Key Ratios
| Ratio | Latest FY | Yoy Change | MRQ | Screener/ About |
|---|---|---|---|---|
| Debt to Equity Ratio | 0.0332 | 319.71 % | 0.0007 | |
| Cash Ratio | 0.111 | -72.88 % | ||
| Quick Ratio | 1.69 | -1.05 % | 1.45 | |
| Shareholders Equity | 64.35 | -1.52 % | ||
| Debt to EBITDA | 0.154 | 482.51 % |
Historical Valuation Ratios of Anuh Pharma Limited
Historical Valuation Ratios
Loading ...
Historical Profitability Ratios of Anuh Pharma Limited
Historical Profitability Ratios
Loading ...
Historical Efficiency Ratios of Anuh Pharma Limited
Historical Efficiency Ratios
Loading ...
Historical Solvency Ratios of Anuh Pharma Limited
Historical Solvency Ratios
Loading ...